No Data
No Data
Limin Group (002734.SZ) has repurchased a total of 14.0537 million shares at a cost of 0.1 billion yuan.
Limin Group (002734.SZ) announced that as of December 31, 2024, the company will conduct centralized auction trading...
Limin's Unit Bags Green Factory Title
Limin Group (002734.SZ) subsidiary awarded the title of national-level green factory.
On December 31, Gelonghui reported that Limin Group (002734.SZ) announced that recently, the Ministry of Industry and Information Technology released the "2024 Annual Green Manufacturing List." According to the related requirements of the "Interim Measures for the Gradient Cultivation and Management of Green Factories," and after recommendations from provincial industrial and information authorities and expert reviews, Limin Holding Group Co., Ltd. (hereinafter referred to as "the Company")'s wholly-owned subsidiary, Limin Chemical Co., Ltd., was awarded the title of "Green Factory."
Limin Group (002734.SZ): Signed a global strategy cooperation agreement with The Cigna Group.
On December 20th, Gelonghui reported that Limin Group (002734.SZ) announced that on December 19, 2024, the company signed a "Global Strategy Cooperation Agreement" with Chengdu Green Cigna Biotechnology Co., Ltd. (hereinafter referred to as "Green Cigna Biotechnology"). Both parties will focus on new biopesticides based on underlying technologies such as small peptide extraction, molecular modification, and synthetic biology, jointly creating, researching, and promoting new agricultural small peptide biological products.
Limin Group (002734.SZ): Limin Chemical has been recognized as a high-tech enterprise.
Liming Group (002734.SZ) announced recently that the national "High-tech Enterprise Recognition Management Work Website" published...
Limin Group (002734.SZ): has a production capacity of 6000 tons of glufosinate-ammonium and 2000 tons of bio-based refined glufosinate-ammonium.
On December 4, Gelonghui reported that Limin Group (002734.SZ) stated in a recent investor relations activity that the company's layout in herbicides is relatively small, with a glyphosate production capacity of 6,000 tons, a bio-based refined glyphosate capacity of 2,000 tons, a nitrosulfonylacetic acid capacity of 1,000 tons, and a cyclic sulfonamide capacity of 500 tons. Currently, herbicide products are at historically low prices, and product prices and gross margins will face certain pressure for a period of time. Limin Group continues to increase investment in technology research and development, continuously improving existing products through technological transformation, cost reduction, and efficiency enhancement to strengthen product competitiveness. The company remains bullish on glyphosate.
No Data